NPR1 and familial dilated cardiomyopathy: Besides, further clinical and translational studies are required to assess the potential therapeutic applications of glucocorticoids and other interventions targeting NPR1 in patients with DCM, particularly those with diuretic resistance and cardiorenal syndrome.